Literature DB >> 16635181

Successful recombinant erythropoietin therapy for a developing anemic newborn with hereditary spherocytosis.

Shigeharu Hosono1, Ako Hosono, Hideo Mugishima, Yuko Nakano, Michiyoshi Minato, Tomo Okada, Shigeru Takahashi, Kensuke Harada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16635181     DOI： 10.1111/j.1442-200X.2006.02191.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN： 1328-8067            Impact factor:   1.524


× No keyword cloud information.
  1 in total

1.  The use of erythropoietin-stimulating agents versus supportive care in newborns with hereditary spherocytosis: a single centre's experience.

Authors:  Jacqueline F Morrison; Ellis J Neufeld; Rachael F Grace
Journal:  Eur J Haematol       Date:  2014-04-16       Impact factor: 2.997
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.